Developing story — details emerging. Check the source link for the latest updates.
Source: [Investing.com](https://www.investing.com/news/sec-filings/twist-bioscience-selected-as-evaluator-for-anthropic-ai-protein-design-project-93CH-4866915)
We are already getting too slow to micromanage agents on individual features. Trying to review and steer every tiny task is quickly becoming the main bottleneck. Managing at the milestone and goal level still feels like something humans can realistically keep up with—at least for now...
What Happened On July 24, 2026, the Claude Opus 5 model logged a sharp rise in error rates across its API endpoints. The status page reported that many requests returned failures instead of the expected responses. The problem lasted several hours and hit applications that use Claude for natural...
1 points, 1 comments on Hacker News
A new study published in the Biophysical Journal reports on the development of a stable, biologically active version of the human fibroblast growth factor. Human fibroblast growth factor, or FGF, has potent wound-healing and antidiabetic properties that could prove useful in the development of n...
Anthropic is preparing to give its founders shares with extra voting power before it goes public, according to The Information. The company is setting up the structure ahead of an initial public offering that could rank among the largest ever, Cory Weinberg and Valida Pau reported. Bloomberg ma...
An 80% reduction in the cost of tokens for OpenAI's Luna allowed Replit to roll out the new service, which despite its 'free' name, still requires a monthly subscription.